[CLSTR]
< Back to situations

[ORGANIZATION]

AstraZeneca

Featured in 54 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [JP] [US] [CN]

Global pharmaceutical and oncology market growth projections

5 clusters · 7 sources · last updated

Latest: Global cancer therapy markets projected to grow significantly by 2030

The global pharmaceutical and oncology markets are projected to experience substantial growth through the early 2030s, driven by innovative therapies and advancements in diagnostics. While total pharmaceutical spending i

[ACTIVE] [HEALTH] [MX]

Cofepris pharmaceutical safety alerts in Mexico

2 clusters · 9 sources · last updated

Latest: Cofepris issues alerts for adulterated and stolen medications in Mexico

Mexico’s Federal Commission for Protection against Sanitary Risks (Cofepris) has issued several health alerts regarding the presence of counterfeit, adulterated, and stolen medications in the country. Initially, Cofepri

[ACTIVE] [BUSINESS] [CN] [US]

China biopharmaceutical industry growth

2 clusters · 13 sources · last updated

Latest: China's biopharma rise reshapes global innovation and dealmaking

China is expanding its national health insurance coverage to include more innovative drugs, specifically targeting cancer, chronic, rare, and pediatric conditions. Since 2018, the National Healthcare Security Administrat

[ACTIVE] [HEALTH] [US]

FDA breast cancer treatment approvals

2 clusters · 7 sources · last updated

Latest: AstraZeneca's Etcamah receives FDA accelerated approval for breast cancer

The U.S. Food and Drug Administration (FDA) has issued approvals for new breast cancer treatments targeting advanced or metastatic cases. Initial approvals included AstraZeneca’s Etcamah (camizestrant), an oral selectiv

[ACTIVE] [BUSINESS] [IT] [US]

Italian financial investment in space economy

4 clusters · 26 sources · last updated

Latest: Intesa Sanpaolo leads Italian high-tech SMEs to Silicon Valley

Italian financial institutions are increasing their involvement in the expanding space economy. Intesa Sanpaolo has acquired a stake in SpaceX, motivated by developments in satellite infrastructure, orbital launches, and

[ACTIVE] [BUSINESS] [GB]

UK ISA tax and regulation changes

5 clusters · 8 sources · last updated

Latest: UK ISA rules to change with new Cash ISA limits in 2027

The regulatory landscape for UK Individual Savings Accounts (ISAs) is set to undergo significant shifts starting April 6, 2027, following the Autumn Budget 2025. Key changes include a 22% charge on cash interest earned w

[ACTIVE] [HEALTH] [FR]

France RSV prevention and reimbursement measures

2 clusters · 5 sources · last updated

Latest: France launches new bronchiolitis prevention campaign

In late August 2026, French health insurance (Assurance Maladie) increased the reimbursement rate for two Respiratory Syncytial Virus (RSV) preventive treatments from 30% to 65%. This change followed a re-evaluation by t

[QUIET] [HEALTH] [EU] [GR] [US]

Advancements in HER2-positive cancer treatments

3 clusters · 7 sources · last updated

Latest: European Commission approves new HER2-positive breast cancer treatment

Regulatory bodies have issued new approvals for treatments targeting HER2-positive cancers. In late August 2026, the European Medicines Agency (EMA) issued a positive opinion for using trastuzumab deruxtecan in combinati

[QUIET] [BUSINESS] [GB] [CN]

AI integration in pharmaceutical development and commerce

2 clusters · 2 sources · last updated

Latest: Pharosyn raises $3 million for pharmaceutical commercial AI

Developments in the pharmaceutical industry highlight the growing role of artificial intelligence in both drug discovery and commercial operations. Pathos AI announced significant expansion of its oncology pipeline thro

[QUIET] [BUSINESS] [JP] [KR]

2 clusters · 6 sources · last updated

Latest: ALGO ARTIS named to Forbes Asia 100 To Watch 2026

[QUIET] [TECHNOLOGY] [US] [CL] [CO]

AI integration in biopharma, science, and healthcare

4 clusters · 49 sources · last updated

Latest: AI and advanced analytics transform biopharma market access

The integration of artificial intelligence across biopharma, scientific research, and healthcare continues to accelerate, marked by significant market growth and clinical advancements. The global AI market for biopharma

[QUIET] [HEALTH] [US] [BR] [EG]

Advances in obesity and weight management treatments

3 clusters · 8 sources · last updated

Latest: Obesity treatment shifts toward oral medications and dietary integration

Medical approaches to obesity and weight management are expanding through a combination of pharmaceutical, surgical, and technological innovations. While bariatric surgeries like sleeve gastrectomies and gastric bypasses

[QUIET] [BUSINESS] [SE] [DE]

European equity market valuation analysis

2 clusters · 2 sources · last updated

Latest: Stockholm Stock Exchange: Analysts identify defensive stocks and growth potential

Market analysts have identified various undervalued and growth-oriented equities across European markets, specifically in Germany and Sweden. In Germany, the defense company Rheinmetall was noted for trading at a signif

[QUIET] [BUSINESS] [SE]

Swedish investment and fund saving trends

2 clusters · 4 sources · last updated

Latest: Swedish investment trends: Portfolios, saving habits, and fund costs

Swedish investment trends show a pattern of seasonal resilience and evolving consumer habits. Historical data from 2010 to 2026 indicates that while fund activity typically drops by one-third in July, this is due to a re

[QUIET] [TECHNOLOGY] [US] [GB] [JP]

AI integration in drug discovery and biotechnology

3 clusters · 12 sources · last updated

Latest: TPC Marketing Research reports on AI drug discovery business strategies

The pharmaceutical and biotechnology sectors are increasingly integrating generative artificial intelligence to accelerate drug discovery and molecular design. Pfizer has entered a licensing agreement with Chai Discover

[QUIET] [HEALTH]

Clinical trial results in oncology and cardiovascular health

2 clusters · 4 sources · last updated

Latest: Clinical trials report mixed results for lung and bladder cancer treatments

Recent medical research and clinical trials have produced varied outcomes across oncology and cardiovascular studies. In oncology, research into breast cancer showed that combining cemiplimab and fianlimab with chemothe

[QUIET] [TECHNOLOGY] [US] [AU] [ID]

AI industry technological and functional expansion

4 clusters · 27 sources · last updated

Latest: AI integration advances in microbiology and computational pathology

The artificial intelligence industry is expanding its scope from digital content generation into hardware development, cybersecurity, and biological design. In the hardware and infrastructure sector, companies like Anth

Also covered in